MEGAN WAJER: Open Payments
NPI 1356886576 · NORTH MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 7 companies in 2025. Trend: 2023 $123 · 2024 $147 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| UCB, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: DUPIXENT, Bimzelx, OPZELURA, YCANTH, Sotyktu, EBGLYSS, SPEVIGO.
Industry payments across MN — which companies pay providers there.
